Fundraising FoxWellington Management — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.
BiotechHealthtech
Lyn Baranowski(CEO)in
Co-investorsAndera PartnersCatalio Capital Management, LPF-Prime CapitalInVivium CapitalNorwest Venture PartnersPivotal Life Sciences+9 more
Launched by Samsara in partnership with CAR T pioneers, advancing a clinically validated CD22 CAR T for lymphoma.
BiotechSan Mateo, US
Gina Chapman(Executive Officer, Director)inAnup Radhakrishnan(Executive Officer)inCassandra Gianna Luca(Director)Jeffrey Walsh(Director)Krishnan Viswanadhan(Director)
BoardAbraham Bassan(Director)
Co-investorsNextech InvestRed Tree VentureSamsara BioCapitalAlly Bridge GroupJanus Henderson InvestorsPerceptive Xontogeny Venture+1 more
Orennia operates an AI-powered energy intelligence platform that combines geospatial data, market fundamentals and analytics to help investors, developers and operators make decisions across the energy transition, including power, storage and emerging energy markets.
AI & Machine LearningClimate TechData & InfrastructureEnergyCalgary, CA
Brook Papau(Co-founder & CEO)inEvan ConleyinTanya Baeza(Co-founder & CFO)
Co-investorsbp venturesNgpQuantum Energy PartnersStronghold Resource PartnersVeriten
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.